Amicus Therapeutics, Inc. (FOLD)
14.20
+3.31
(+30.39%)
USD |
NASDAQ |
Dec 19, 16:00
14.16
-0.04
(-0.28%)
After-Hours: 20:00
Amicus Therapeutics Shareholders Equity (Annual): 194.04M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| CorMedix, Inc. | 84.66M |
| ACADIA Pharmaceuticals, Inc. | 732.79M |
| ANI Pharmaceuticals, Inc. | 403.68M |
| Beam Therapeutics, Inc. | 733.54M |
| Catalyst Pharmaceuticals, Inc. | 727.63M |